Oncologix Tech, Inc. (OCLG)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2017 2016
Revenue - - - - 2.85 Million 4.01 Million
Cost of Revenue - - - - 2.27 Million 2.79 Million
Gross Profit - - - - 571.56 Thousand 1.21 Million
Operating Expenses - - - - 1.43 Million 1.72 Million
Selling, General and Administrative Expenses - - - - 1.43 Million 1.72 Million
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses - - - - 3.71 Million 4.52 Million
Operating Income - - - - -864.95 Thousand -512.44 Thousand
Interest Expense - - - - 1.24 Million 698.05 Thousand
Income Tax Expense - - - - 3.00 1.00
Earnings before Tax - - - - -2.37 Million -1.84 Million
Net Income - - - - -2.37 Million -1.84 Million
Earnings Per Share Basic - - - - -0.00 -0.00
Earnings Per Share Diluted - - - - -0.00 -0.00
Weighted Average Shares Outstanding 1.66 Billion 1.51 Billion 1.51 Billion 1.51 Billion 736.61 Million 719.83 Million
Weighted Average Shares Outstanding (Diluted) 1.66 Billion 1.51 Billion 1.51 Billion 1.51 Billion 736.61 Million 719.83 Million
Gross Margin - - - - 0.20 0.30
EBIT Margin - - - - -0.30 -0.12
Profit Margin - - - - -0.83 -0.46
EBITDA - - - - -1.11 Million -1.13 Million
Earnings Before Tax Margin - - - - -0.30 -0.13

Income Statement Charts